ASIA CEMENT CH (00743) reported a loss attributable to shareholders of RMB301 million for the first three quarters.
Asia Cement (China) (00743) announced that for the nine months ended September 30, 2026, revenue was RMB3.329 billion, down 10.8% year-on-year; loss attributable to owners of the company was RMB301 million, compared with a profit of RMB146 million in the same period last year; basic loss per share was RMB0.192.
ASIA CEMENT CH (00743) announced that for the nine months ended September 30, 2026, revenue was RMB3.329 billion, down 10.8% year-on-year; loss attributable to owners of the company was RMB301 million, compared with a profit of RMB146 million in the same period last year; basic loss per share was RMB0.192.
Related Articles
.png)
DAWNRAYS PHARMA (02348) repurchased 216,000 shares on October 27 for HK$202,200.
SIMCERE PHARMA (02096) repurchased 1.042 million shares on October 27 for approximately HK$10.751 million.
JF SMARTINVEST (09636) repurchased 140,700 shares on October 27 for approximately HK$3.6401 million.
DAWNRAYS PHARMA (02348) repurchased 216,000 shares on October 27 for HK$202,200.
SIMCERE PHARMA (02096) repurchased 1.042 million shares on October 27 for approximately HK$10.751 million.
JF SMARTINVEST (09636) repurchased 140,700 shares on October 27 for approximately HK$3.6401 million.
